A Diagnostic Approach for Rodent Progressive Cardiomyopathy and Like Lesions in Toxicology Studies up to 28 Days in the Sprague Dawley Rat (Part 1 of 2)
Author(s) -
James R. Hailey,
Beverly E. Maleeff,
Heath C. Thomas,
Gail Pearse,
Jan Klapwijk,
Patrizia Cristofori,
Brian R. Berridge,
Carie L. Kimbrough,
George A. Parker,
Daniel Morton,
Susan A. Elmore,
Jerry F. Hardisty,
Noël Dybdal,
David Rehagen,
James Fikes,
Martin Lamb,
Kathleen Biddle,
Bernard S. Buetow,
Vinicius Carreira,
Abraham Nyska,
Niraj Tripathi,
Heather C. Workman,
Jean-Guy Bienvenu,
Ingrid Brees,
James R. Turk,
Rick R. Adler
Publication year - 2017
Publication title -
toxicologic pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.613
H-Index - 108
eISSN - 1533-1601
pISSN - 0192-6233
DOI - 10.1177/0192623317743938
Subject(s) - medicine , cardiomyopathy , lesion , pathology , radiology , heart failure
Spontaneous rodent progressive cardiomyopathy (PCM) in the Sprague Dawley rat may confound identification and/or interpretation of potential test article (TA)-related cardiotoxicity. Pathologists apply diagnostic term(s) and thresholds for diagnosing and assigning severity grades for PCM and/or PCM-like (PCM/like) lesions consistently within a study, which is necessary to identify and interpret TA-related findings. Due to differences in training and/or experiences, diagnostic terms and thresholds may vary between pathologists. Harmonized terminology and thresholds across studies will generate better historical control data, will likely enhance interpretation of study data, and may further enhance our understanding of the spontaneous change. An assessment of the diagnostic approaches of a group of 37 pathologists identified an approach that is relatively easily applied; and if adopted, it could enhance diagnostic consistency across studies. This approach uses the single “slash” term “necrosis/inflammatory cell infiltrate (NICI)” as the diagnosis for the spectrum of lesions seen in younger rats, uses no threshold for diagnosis (e.g., diagnose all lesions clearly identifiable as PCM/like), and uses aggregate lesion size of approximately ≥45% of the field of view (FOV) using a 10×/22 eyepiece and the 40× objective or approximately ≥100% of the FOV using the 60× objective as the criterion separating minimal from mild severities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom